Freestone Capital Holdings’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$941K Sell
37,245
-15,282
-29% -$390K 0.03% 241
2025
Q4
$1.34M Buy
52,527
+8,422
+19% +$216K 0.04% 207
2025
Q3
$1.13M Buy
+44,105
New +$1.12M 0.03% 232

Other funds holding IBDX

Freestone Capital Holdings's IBDX Position: Q1 2026 in Review

Freestone Capital Holdings reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 29% in Q1 2026, selling an estimated $390K and leaving 37,245 shares worth $941K. The position accounts for 0.03% of the portfolio, ranked #241.

Freestone Capital Holdings first reported a position in IBDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.34M in Q4 2025. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Freestone Capital Holdings held 37,245 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $941K as of Q1 2026.
  • Freestone Capital Holdings sold 15,282 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $390K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.03% of Freestone Capital Holdings's portfolio in Q1 2026, its #241 holding.
  • Freestone Capital Holdings first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 3 quarters since.
  • Freestone Capital Holdings's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.34M in Q4 2025.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.